Ooooh, disruption, how cool is that, Sana Benefits reels in $6.3 million in new capital for its software that will fix the "stone age" health insurance industry. It is targeting medium and small employer plans. All it will end up doing is adding cost and complexity.
Scary stuff, boys and girls, investing in the hype of the moment. A company called Socially Determined has garnered $7.3 million in financing for its product that focuses on analyzing and measuring the social determinants of health. Not a ghost of a chance that this succeeds. It will be a zombie company, like a vampire sucking more funds from investors.
Workday Ventures tries to get in a league of its own, as it makes a significant investment in League, which offers software to help employers manage health benefits.
Broad-based health management company Medecision decides to buy GSI Health, which offers software to help providers with value-based payment arrangements, particularly for Medicaid business.
Amazon adds to its health capabilities by purchasing Health Navigator, which offers online symptom checking and triage tools designed to help steer patients to appropriate treatment paths.
Australia-based firm MedAdvisor, which provides an app to help patients manage the medications, raises $11.5 million in new financing, led by HMS Holdings.
Avia flys off with $22 in new funding for its digital health insights business, and I have no idea what value they actually bring to their health system customers and investors but the press release is full of disruption, etc. etc.
Octave Health strikes a positive note, collecting $11 million in new capital to support its behavioral health business which matches patients with in-person or telehealth care.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.